6-28326778-A-C
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_030899.5(ZSCAN31):āc.609T>Gā(p.Asp203Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000157 in 1,613,780 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_030899.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ZSCAN31 | NM_030899.5 | c.609T>G | p.Asp203Glu | missense_variant | 4/4 | ENST00000344279.11 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ZSCAN31 | ENST00000344279.11 | c.609T>G | p.Asp203Glu | missense_variant | 4/4 | 1 | NM_030899.5 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000171 AC: 26AN: 152184Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000244 AC: 61AN: 250312Hom.: 0 AF XY: 0.000310 AC XY: 42AN XY: 135400
GnomAD4 exome AF: 0.000156 AC: 228AN: 1461478Hom.: 2 Cov.: 33 AF XY: 0.000191 AC XY: 139AN XY: 727088
GnomAD4 genome AF: 0.000171 AC: 26AN: 152302Hom.: 0 Cov.: 32 AF XY: 0.000201 AC XY: 15AN XY: 74482
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 13, 2024 | The c.609T>G (p.D203E) alteration is located in exon 4 (coding exon 3) of the ZSCAN31 gene. This alteration results from a T to G substitution at nucleotide position 609, causing the aspartic acid (D) at amino acid position 203 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at